Financhill
Back

Stoke Therapeutics, Inc. Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing slight selling pressure.

Stoke Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 29.31 Buy
20-day SMA: 31.08 Sell
50-day SMA: 30.93 Sell
200-day SMA: 20.46 Buy
8-day EMA: 15.57 Buy
20-day EMA: 7.63 Buy
50-day EMA: 3.33 Buy
200-day EMA: 0.87 Buy

Stoke Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.53 Buy
Relative Strength Index (14 RSI): 44.61 Sell
Chaikin Money Flow: -82403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.47 - 33.17) Sell
Bollinger Bands (100): (24.73 - 32.95) Buy

Stoke Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Stoke Therapeutics, Inc. Stock

Is Stoke Therapeutics, Inc. Stock a Buy?

STOK Technical Analysis vs Fundamental Analysis

Sell
50
Stoke Therapeutics, Inc. (STOK) is a Sell

Is Stoke Therapeutics, Inc. a Buy or a Sell?

Stoke Therapeutics, Inc. Stock Info

Market Cap:
1.7B
Price in USD:
29.51
Share Volume:
328.2K

Stoke Therapeutics, Inc. 52-Week Range

52-Week High:
38.69
52-Week Low:
5.35
Sell
50
Stoke Therapeutics, Inc. (STOK) is a Sell

Stoke Therapeutics, Inc. Share Price Forecast

Is Stoke Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Stoke Therapeutics, Inc.

Is Stoke Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.21 per share, and an increase next year of $0.76 per share.

Technical Analysis of Stoke Therapeutics, Inc.

Should I short Stoke Therapeutics, Inc. stock?

* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.